VieMed Healthcare (Nasdaq: VMD) credited … [Read more...]
VieMed Q3 Earnings Call: Diversification, Lehan’s Acquisition Key to Strong Performance
Resmed’s Mask Portfolio, Education Efforts Lauded in Q1 Earnings Call
The manufacturer is focusing on both mask launches and mask resupply success.
Masks to treat sleep apnea drove strong … [Read more...]
Resmed Launches AirTouch F30I Clear Full-Face Mask
The new CPAP mask is designed for comfort and to facilitate sleep.
Resmed’s latest full-face mask launch was made … [Read more...]
Encore Healthcare’s Educational Conference Returning in October
The Smoky Mountain Symposium offers CEU courses for sleep, respiratory professionals.
The Smoky Mountain Symposium (SMS) — a continuing … [Read more...]
Research: US Obstructive Sleep Apnea Numbers to Rise Nearly 35% by 2050
A new study estimates 76.6 million adults in America, aged 30-69, will have OSA by then.
A new research study published in The Lancet … [Read more...]
Resmed Launches Clinically Focused Sleep Institute for Research, Education
The initiative aims to close a “system-wide gap in sleep health innovation.”
Resmed has launched a new, clinically focused … [Read more...]
AdaptHealth Reports Flat Q2 Earnings, ‘Gaining Momentum’ as Competitive Bidding Looms
CEO Suzanne Foster also announced an agreement to become the exclusive provider of HME for major national health-care systems.
AdaptHealth Corp. (Nasdaq: AHCO) reported flat … [Read more...]
New Research Focuses on Impact of Environment, Activities on Obstructive Sleep Apnea
Two new studies examined sleep data for more than 70,000 participants.
Two newly published research studies examine the … [Read more...]
Fisher & Paykel Launches ‘Powered by Curiosity’ Full-Face Mask Campaign
The manufacturer’s new focus follows marketing campaigns for its nasal and nasal pillows sleep apnea masks.
Fisher & Paykel Healthcare (NZX: FPH, OTC: … [Read more...]
Resmed CEO Mick Farrell Discusses Strong Q4 Results, Tariff Impact During Earnings Call
Resmed aims to support more than 500 million patients by 2030.
Resmed reported strong fourth-quarter fiscal year … [Read more...]